patients NIV could avoid the need for inBackground -A study was undertaken to tubation in 50-70% of cases, thus reducing investigate the effects of non-invasive as-significantly the morbidity and duration of hossist-control ventilation (ACV) by nasal pital stay.
was investigated fasting, in a semirecumbent position in bed, and in quiet conditions. Throughout the study patients were asked to close their mouth firmly in order to limit the deleterious effect of air leaks. 13 All patients were randomly submitted to two consecutive NIV sequences via the same ventilator and nasal mask for a minimal duration of 30 minutes. One sequence in spontaneous breathing (SB) and supplemented with inspired oxygen was used as the patient's own control period, the patient breathing spontaneously through the ventilator circuit and nasal mask without any associated pressure support level. The other sequence was conducted in ACV mode. The patient was informed of the change in sequence, but was not aware of the type of ventilatory mode used (SB or ACV). Initial settings for ACV were those usually reported with NIV: 7 11 insufflated tidal volume (V) of 15-20 ml/kg, respiratory rate (RR) of 12-20 cycles/min, T/T ratio of to 1/3, inspired oxygen fraction (Fi 2 ) enabling arterial oxygen saturation (Sa 2 ) of [90%, constant flow rate of 60 l/ min, trigger sensitivity of −0.5 cm H 2 O. If necessary, these initial settings (V, RR) were subsequently adjusted and thus optimised in relation to the patient's clinical tolerance and the presence or absence of air leaks around the mask before performing the measurements. The Fi 2 did not change between SB and ACV. All measurements were made at the end of each 
parameters (V , VT, Paw), oesophageal pressure (Poes), diaphragmatic electromyographic activity (raw and integrated EMGdi), and end tidal carbon dioxide fraction (FETCO 2 )
stable and appropriate ventilation.
during non-invasive ventilation with spontaneous breathing (SB) and assist-control
Patients were observed clinically by a phys- by continuous monitoring of heart rate, noninvasive blood pressure, and transcutaneous Methods The study was conducted in a medical intensive oximetry (Biox 3700, Ohmeda Inc, Boulder, Colorado, USA). care unit and approved by the ethical committee of the Charles Nicolle University Hospital. All patients gave their written informed consent. Patients enrolled in the study had  All patients were ventilated using the same known COPD or a high probability of the disease on the basis of the clinical history, ventilator (Evita 2, Dräger Medical Inc, Lubeck, Germany) and were connected to the physical examination, chest radiography, and/ or previous pulmonary function test data. Ad-ventilator via a tightly fitting nasal mask (Respironics, Murrysville, Pennsylvania, USA). ditional criteria for enrollment included hypercapnic acute respiratory failure requiring NIV The humidifier of the ventilator circuit was disconnected during the trial to decrease the according to the following criteria: 2 4 tachypnoea >25/min or bradypnoea Ζ12/min, Pa 2 workload necessary to overcome the circuit resistances. The following general data were Ζ8 kPa (60 mm Hg) in ambient air, Pa 2 [6.5 kPa (49 mm Hg) in ambient air or wor-recorded for all patients: past history, current diseases and treatment, arterial blood gas sening with a low nasal oxygen flow (Ζ3 l/min), respiratory acidosis (pH Ζ7.35), a normal level tensions on admission, and simplified acute physiological score (SAPS). 20 Each patient was of consciousness or moderate signs of respiratory encephalopathy (drowsiness, con-investigated using the same apparatus and polygraphic recorder (fig 1) . Instantaneous flow fusion, flapping tremor). Patients were included if they showed at least three of these rate was measured using a pneumotachograph The respiratory comfort (level of dyspnoea, and the nasal mask, was measured on the Poes well being) was assessed in the last minutes of curve as the difference between point 0 and each ventilation sequence on a 100 mm visual the Poes point corresponding to cancellation analogue scale (VAS). The patient's status was of insufflation flow, 24 averaged from 10 replocated between a value of 0 ("I don't feel at resentative cycles. Total inspiratory work of all comfortable") and 100 ("I feel very combreathing (WOBinsp) was determined using fortable") and converted into a numerical value Campbell's diagram method 25 by integration of for statistical analysis. Preference for each of the area plotted between the pressure-volume the two modes was also noted. (Poes-V) and the chest wall compliance (Cw) curves. 26 27 Since it is impossible to measure Cw without complete relaxation, we assumed,   as others have, 28 29 that it was equal to 4% of The primary end point involved comparison of the theoretical vital capacity. 30 WOBinsp was respiratory muscle function parameters, gas calculated from the mean of five cycles and exchange, and breathing pattern between the expressed in joules (J). WOBinsp thus enabled SB and ACV modes. The secondary end point calculation of WOBinsp in relation to V evaluated the clinical respiratory comfort with (WOBinsp/V in J/l) or to RR (WOBinsp/RR these two modes. Qualitative data assessed by in J/min). Pressure time product (PTP), a better VAS were subsequently converted into nuindicator of the energy expenditure of res-merical values in millimetres. Due to the crosspiratory muscles, 31 32 was obtained from the over design of the trial, we performed a nonproduct of T and the area under the Poes curve parametric test for carry-over (interaction), corresponding to T. In addition to Poes, period and treatment effects using the MannWOBinsp and PTP, respiratory muscle activity Whitney U test to compare results between SB was evaluated by the diaphragmatic electro-and ACV sequences. 35 The Wilcoxon test for myogram (EMGdi) activity amplitude with bi-paired data was used to compare arterial blood polar skin surface electrodes. 33 The EMGdi gas tensions on admission with those obtained signal obtained (raw EMGdi) was then amp-with ACV and SB mode. Results were exlified (Universal amplifier 13-4615-58, Gould pressed as mean (SD) for ACV and SB sepElectronics Inc, Cleveland, Ohio, USA) and arately and median differences and ranges filtered (30-300 Hz), rectified and elec-(ACV-SB). A difference was considered to be tronically integrated every 100 ms (integrated statistically significant for an alpha probability EMGdi) to obtain a moving time average which of less than 0.05 (p <0.05). was then analysed using the method of Lopata et al. 34 The diaphragmatic activity was evaluated by the maximum or peak amplitude of Results the integrated EMGdi signal (pEMGdi). This The main clinical and respiratory charquantitative value, averaged from 10 cycles, acteristics of the 15 patients with COPD are was also expressed as a percentage of the con-shown in table 1. All showed evidence of severe trol value obtained in SB.
hypercapnic ACRF requiring NIV. These The end tidal carbon dioxide fraction ACRF episodes were related to bronchial in-(F 2 ) and Sa 2 were measured con-fection in 14 cases and to pneumonia in one tinuously, respectively, at the mask using a case (patient 3). Table 1 also shows the main rapidly responding CO 2 analyser (Medical Gas ventilatory settings used in ACV mode during Analyzer LB-2, Sensor Medics Corp, Anaheim, the trial after optimisation. No evidence was California, USA) and by transcutaneous pulsed found for any carry-over (interaction) or period oximetry (Biox 3700, Ohmeda Inc, Boulder, effects so all the results presented are for the Colorado, USA). Arterial blood gas tensions, non-parametric treatment effects. was found between arterial blood gas tensions on admission and those obtained with SB mode. During the trial oxygenation parameters NIV with ACV mode in the treatment of acute group.bmj.com on June 22, 2017 -Published by http://thorax.bmj.com/ Downloaded from exacerbations of COPD. It shows that, during ing NIV due to a poorly fitting mask or unsuitable settings also increase respiratory NIV, ACV acts by reducing total WOBinsp while at the same time improving breathing workload.
13 Despite these possible limitations we found that non-invasive ACV can, like endopattern and gas exchange. Despite optimised settings adapted to the clinical tolerance of tracheal ventilation, achieve one of the goals of assisted ventilation which is to provide muscle patients, these beneficial physiological effects are achieved at the expense of respiratory dis-rest. 4 Complete muscle rest could not be achieved during the trial because a certain decomfort which is experienced by all patients in comparison with the SB mode.
gree of muscle activity persists with ACV, although this activity is close to normal. 30 This The conditions of this study involved the usual emergency situation in which such is because we used a patient triggered mode of ventilation (ACV) to assist our patients. Even patients are admitted. We used initial ACV settings as previously reported 7 11 but it proved with endotracheal ventilation, ACV may allow considerable respiratory effort to persist which necessary in most patients to change these settings subsequently for reasons of tolerance can be similar to the effort needed with SB.
37 42
The interpretation of WOBinsp may be or air leaks around the nasal mask. We found that a lower than recommended 7 11 mean in-difficult with NIV so we combined measurement of the EMGdi. It has been shown that sufflated V of 9 ml/kg provided a significant, and probably sufficient, reduction in WOBinsp during NIV the surface EMGdi activity was well correlated with that of EMGdi assessed by with improved breathing pattern. This optimisation was nevertheless subject to in-invasive oesophageal electrodes.
13 43 The results parallelled those of WOBinsp -that is, a subterindividual variations which had to be taken into account when interpreting our results and stantial reduction in surface EMGdi amplitude occurred with the ACV mode. The decrease setting ventilators. It is thus probable that settings suggested up to now 7 11 -which can be in WOBinsp and EMGdi with non-invasive ACV was also supported by the decrease in obtained only at the price of an increased Paw (that is, by increasing V with ACV) -would Poes and PTP. These parameters, which are easier to obtain and interpret in clinical prachave led to a greater decrease in WOBinsp but at the expense of more patient discomfort. It tice, are also good indices of muscle energy expenditure and oxygen consumption in reis essential to take this fact into account when choosing initial settings from NIV. Fur-sponse to the ventilatory drive of patients.
31 32
Our results support those of previous physiothermore, our settings did not cause any significant variation in PEEPi,dyn which may logical studies of NIV in ACRF.
2 12 13 These studies mainly investigated PSV 2 12 rather than contribute, particularly in COPD, 36 to an additional imposed workload via dynamic hyper-the ACV mode. 13 The WOBinsp was not calculated but a significant reduction was found inflation as has sometimes been observed with non-invasive PSV. 2 12 The optimised settings in transdiaphragmatic pressure (Pdi), PTP, 2 12 electrical activity of the diaphragm, 2 12 13 and presented in this study could constitute baseline settings for future use of non-invasive ACV.
Poes in patients with chronic obstructive or restrictive respiratory disease. 13 Similar results We used several parameters to evaluate inspiratory muscle function, and more especially with PSV using a mask have also been reported in patients with stable COPD. 14-17 To the best that of the diaphragm. To the best of our knowledge, calculation of WOBinsp with NIV of our knowledge, no previous study has specifically evaluated the physiological effects of is reported here for the first time. During ACV we did not calculate the work performed by ACV during NIV in a large population of COPD patients with ACRF. Carrey et al 13 first the patient as the difference between ventilator work during assisted and controlled mechanical reported the effects of NIV on inspiratory muscle activity. However, they used a pressure breaths with identical flow rates and tidal volumes 37 because this method is not applicable control mode and only investigated two patients with COPD in ACRF of a study popuduring SB.
Our results demonstrate a significant re-lation of 12 subjects. Our study also shows that NIV with ACV duction in muscle activity indices when using NIV with the ACV mode compared with the mode enables an improvement in the breathing pattern as has already been shown with PSV SB mode, with Poes, WOBinsp/V, WOBinsp/RR, and PTP being influenced the most. in other patients.
2 12 ACV thus acts essentially as expected by increasing alveolar ventilation The baseline total workload was changed from a value that was close to the diaphragmatic (V) and reducing RR with consequent improvement in arterial blood gas tensions. It is fatigue threshold of 1.40 J/l 38 to a normal value of 0.30-0.65 J/l. 30 This difference in total possible that the arterial blood gas tensions in our patients could have improved sponWOBinsp between the SB and ACV modes could be due in part to the workload necessary taneously during the delay (mean (SD) 19. 2 (11.48) hours) between their admission and to overcome the circuit and demand valve resistances. 29 Nevertheless, as explained below, the start of the study. However, the blood gas tensions during SB did not differ from the most of the cycles were also triggered during ACV in our patients. Interestingly, the WOB admission values, suggesting this did not occur.
Our arterial blood gas tensions are in agreement of the patients with the ACV mode was less than that reported in other studies with invasive with those of numerous clinical [1] [2] [3] [4] [5] [6] [7] [8] and physiological 12 studies with NIV in ACRF. Our findendotracheal ventilation.
31 37 39 The size of the endotracheal tubes can greatly influence the ings indicate that improved alveolar ventilation can be expected within 30 minutes of starting muscular effort required, 40 41 and air leaks dur- 
